Reported figures and Equlion model projections for the next 5 years.
ROE
+69.9 pt
Company
ROA
-54.3 pt
Company
Gross Margin
-14.3 pt
Company
Sector average
Net Margin
-66.9 pt
Company
Total Assets
+87%
Company
Sector average
Net Income
-16,201.5%
Company
Sector average (own scale)
Detailed data
AUD|Millions
Amounts in AUD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for TELIX PHARMACEUTICALS LIMITED? It covers the balance sheet, income statement, cash flow and Equlion model projections.